DOI QR코드

DOI QR Code

Holographic Quantitative Structure-Activity Relationship (HQSAR) Study of 3,4-Dihydroxychalcone Derivatives as 5-Lipoxygenase Inhibitors

  • Gadhe, Changdev G. (Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research)
  • Received : 2011.07.12
  • Accepted : 2011.08.31
  • Published : 2011.09.30

Abstract

Holographic quantitative structure-activity relationships (HQSAR) is a useful tool to correlates structures with their biological activities. HQSAR is a two dimensional (2D) QSAR methodology, which generates QSAR equations through 2D fingerprint and correlates it with biological activity. Here, we report a 2D-QSAR model for a series of fifty-one 3,4-dihydroxychalcones derivatives utilizing HQSAR methodology. We developed HQSAR model with 6 optimum numbers of components (ONC), which resulted in cross-validated correlation coefficient ($q^2$) of 0.855 with 0.283 standard error of estimate (SEE). The non-cross-validated correlation coefficient (r2) with 0.966 indicates the model is predictive enough for analysis. Developed HQSAR model was binned in to a hologram length of 257. Atomic contribution map revealed the importance of dihydroxy substitution on phenyl ring.

Keywords

References

  1. S. E. Dahlen, P. Hedqvist, S. Hammarstrom, and B. Samuelsson, "Leukotrienes are potent constrictors of human bronchi", Nature, Vol. 288, pp.484- 486, 1980. https://doi.org/10.1038/288484a0
  2. J. M. Drazen, K. F. Austen, R. A. Lewis, D. A. Clark, G. Goto, A. Marfat, and E. J. Corey, "Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro", Proc. Nat. Acad. Sci., Vol. 77, pp.4354-4358, 1980. https://doi.org/10.1073/pnas.77.7.4354
  3. R. D. Camp, A. A. Coutts, M. W. Greaves, A. B. Kay and M. J. Walport, "Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4", Br. J. Pharmacol., Vol. 80, pp. 497-502, 1983. https://doi.org/10.1111/j.1476-5381.1983.tb10721.x
  4. A. W. Ford-Hutchinson, M. A. Bray, M. V. Doig, M. E. Shipley and M. J. H. Smith, "Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes", Nature, Vol. 286, pp. 264-265, 1980. https://doi.org/10.1038/286264a0
  5. J. H. Musser and A. F. Kreft, "5-Lipoxygenase: Properties, Pharmacology, and the Quinotinyl (bridged) Aryl Class of Inhibitors", J. Med. Chem., Vol. 35, pp. 2501-2524, 1992. https://doi.org/10.1021/jm00092a001
  6. D. G. Batt, G. D. Maynard, J. J. Petraitis, J. E. Shaw, W. Galbraith and R. R. Harris, "2-Substituted-1- naphthols as Potent 5-Lipoxygenase Inhibitors with Topical Antiinflammatory Activity", J. Med. Chem., Vol. 33,pp. 360-370, 1989.
  7. G. H. Jones, M. C. Venuti, J. M. Young, D. V. K. Murthy, B. E. Loe, R. A. Simpson, A. H. Berks, K. C. Kappas, C. C. Beard, S. H. Unger and P. Cheung, "Topical Nonsteroidal Antipsoriatic Agents. 1.1,2,3, 4-Tetraoxygena-N aphthalene Derivatives", J. Med. Chem. Vol. 29, pp. 1504-1511, 1986. https://doi.org/10.1021/jm00158a031
  8. H. Degreef, P. Docks, P. De Doncker, K. De Beule and G. Cauwenbergh, "A Double-Blind Vehicle- Controlled Study of R-68-131 in Psoriasis - A Topical 5-Lipoxygenase Inhibitor", J. Am. Acad. Dermatol., Vol. 22, pp. 751-755, 1990. https://doi.org/10.1016/0190-9622(90)70103-O
  9. D. G. Batt, "5-Lipoxygenase Inhibitors and Their Anti-inflammatory Activities", Progr. Med. Chem., Vol. 29, pp. 1-63, 1992.
  10. P. Bruneau, C. Delvare, M. P. Edwards and R. M. McMillan, "Indazolinones, a New Series of Redox- Active 5-lipoxygenase Inhibitors with Built In Selectivity and Oral Activity", J . Med. Chem., Vol. 34, pp. 1028-1036, 1991. https://doi.org/10.1021/jm00107a023
  11. T. Nakadate, E. Aizu, S. Yamamoto and R. Kato, "Effects of Chalcone Derivatives on Lipoxygenase and Cyclooxygenase Activities of Mouse Epidermis", Prostaglandins, Vol. 30, pp. 357-367, 1985. https://doi.org/10.1016/0090-6980(85)90112-1
  12. S. Sogawa, Y. Nihro, H. Ueda, A. Izumi, T. Miki, H. Matsumoto and T. Satoh, "3, 4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors", J. Med. Chem., Vol. 36, pp. 3904-3909, 1993. https://doi.org/10.1021/jm00076a019
  13. S. H. R. SYBYL8.1; Tripos Inc. St. Louis, MO 63144 USA.
  14. T. Hurst and T. Heritage, "HQSAR-A highly predictive QSAR technique based on molecular holograms", 213th ACS Natl. Meeting San Francisco, CA, 1997, CINF 019; 1997.
  15. S. Ash, M. A. Cline, R. W. Homer, T. Hurst and G. B. Smith, "SYBYL Line Notation (SLN): A Versatile Language for Chemical Structure Representation", J. Chem. Inf. Comput. Sci., Vol. 37, pp. 71- 79, 1997. https://doi.org/10.1021/ci960109j